Effect of edetate calcium disodium on yttrium-90 activity in bone of mice

Annals of Nuclear Medicine

Volumn 13, Issue 6, 1999, Pages 397-400

  Watanabe, Naoyuki ^b   Oriuchi, Noboru ^c   Tanada, Shuji ^c   Murata, Hajime ^c   Inoue, Tomło ^c   Kim, E Edmund ^a   Sasaki, Yasuhito ^c   Endo, Keigo ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c NONE

Author keywords

Bone uptake; Edetate calcium disodium

Indexed keywords

EDETATE CALCIUM DISODIUM; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE LEVEL; CHELATION; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG HALF LIFE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; TISSUE LEVEL;

EID: 0033402531     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164933     Document Type: Article

References (11)

1. Hnatowich DJ, Chinol M, Siebeker DA, Gionet M, Griffin T, Doherty PW, et al. Patient biodistribution of intraperitoneally administered yttrium-90 labeled antibody. J Nucl Med 29: 1428-1434, 1988.
2. Sharkey R, Kaltovich FA, Shih LB, Fand I, Govelitz G, Goldenberg DM. Radioimmunotherapy of human colonie cancer xenografts with yttrium-90 labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res 48: 3270-3275, 1988.
3. MacDonald NS, Nusbaum RE, Alexander GV, Ezmirlian F, Spain P, Rounds DE. The skeletal deposition of yttrium. J Biol Chem 195: 837-841, 1952.
4. Jowsey J, Sissons HA, Vaughan J. The site of deposition of Y-91 in the bones of rabbits and dogs. J Nucl Energy 2: 168-176, 1956.
5. Jowsey J, Rowland RE, Marshall JH. The deposition of the rare earths in bone. Rad Research 8: 490-501, 1958.
6. Durbin PW. Metabolic characteristics within a chemical family. Health Phys 2: 225-238, 1960.
7. Vaughan JM, Tutt ML. Use of ethylene diamine tetraacetic acid (versene) for removing fission products from the skelton. Lancet 2: 856-859, 1953.
8. 90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTA. Int J Radiation Oncology Biol Phys 28: 1257-1265, 1994.
9. Stewart JSW, Hird V, Snook D, Dhokia B, Sivalapenko G, Hooker G, et al. Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer. J Clin Oncol 8: 1941-1950, 1990.
10. 2EDTA for improvement of radioimmunodetection and radioimmunotherapy with indium-111 and yttrium-90-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer. J Nucl Med (in press)
11. Klaassen CD. Toxicology. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds.), 8th ed., New York, Pergamon Press, Inc., pp. 1592-1614, 1990.